AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $176,000 | -98.9% | 70,000 | -94.3% | 0.00% | -98.9% |
| Q2 2020 | $16,695,000 | +1319.6% | 1,229,346 | +309.8% | 0.18% | +1000.0% |
| Q3 2019 | $1,176,000 | -18.7% | 300,000 | 0.0% | 0.02% | -11.1% |
| Q2 2019 | $1,446,000 | -41.1% | 300,000 | 0.0% | 0.02% | -41.9% |
| Q1 2019 | $2,457,000 | +48.1% | 300,000 | 0.0% | 0.03% | +24.0% |
| Q4 2018 | $1,659,000 | +168.4% | 300,000 | +328.6% | 0.02% | +212.5% |
| Q3 2018 | $618,000 | -30.6% | 70,000 | -8.5% | 0.01% | -57.9% |
| Q4 2014 | $890,000 | – | 76,485 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |